These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24147515)

  • 1. Torsades de pointes following clarithromycin treatment.
    Gysel M; Vieweg WV; Hasnain M; Hancox JC; Kunanithy V; Baranchuk A
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1485-93. PubMed ID: 24147515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes due to drug interaction between disopyramide and clarithromycin.
    Choudhury L; Grais IM; Passman RS
    Heart Dis; 1999; 1(4):206-7. PubMed ID: 11720625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac arrest and electrical storm due to recurrent torsades de pointes caused by concomitant clarithromycin, cotrimoxazole and amiodarone treatment.
    Bienias P; Ciurzyński M; Paczyńska M; Pruszczyk P
    Pol Merkur Lekarski; 2014 Nov; 37(221):285-8. PubMed ID: 25546990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin-Induced Torsades de Pointes.
    Chang NL; Shah P; Bikkina M; Shamoon F
    Am J Ther; 2016; 23(3):e955-6. PubMed ID: 25057773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clarithromycin-induced torsades de pointes].
    Yamaguchi S; Kaneko Y; Yamagishi T; Ohyama Y; Amano M; Arai M; Nakamura T; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2003 Jan; 92(1):143-5. PubMed ID: 12652715
    [No Abstract]   [Full Text] [Related]  

  • 7. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin induced torsade de pointes.
    Hensey C; Keane D
    Ir J Med Sci; 2008 Mar; 177(1):67-8. PubMed ID: 17618400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced torsades de pointes in patients aged 80 years or more.
    Paran Y; Mashav N; Henis O; Swartzon M; Arbel Y; Justo D
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):260-5. PubMed ID: 18676301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron.
    Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB
    Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An unusual cause of cardiac arrest].
    Campana A; Manzo M; Brigante M; Marrazzo N; Melchiorre G
    Ital Heart J Suppl; 2003 Jun; 4(6):510-3. PubMed ID: 19400057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmic potential of antimicrobial agents.
    Simkó J; Csilek A; Karászi J; Lorincz I
    Infection; 2008 Jun; 36(3):194-206. PubMed ID: 18454341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsade de pointes induced by cisapride/clarithromycin interaction.
    Piquette RK
    Ann Pharmacother; 1999 Jan; 33(1):22-6. PubMed ID: 9972380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.